OTS is reliable in predicting paediatric cataract visual outcome

Article

The Ocular Trauma Score (OTS) is a reliable predictor of final visual outcome in children with traumatic cataract

The Ocular Trauma Score (OTS) is a reliable predictor of final visual outcome in children with traumatic cataract, according to a paper featured in the Journal of Cataract and Refractive Surgery.

The retrospective cohort study, led by Dr Mehul A. Shah, Drashti Netralaya, Gujarat, India, included 354 children with traumatic cataract. Each child was examined and reviewed for comorbidities caused by trauma.

Surgery and IOL implantation was performed for each patient and each was treated for amblyopia, if necessary. Six weeks postoperatively all patients were re-examined. Patients were divided into two traumatic cataract groups- open-globe injury and close-globe injury. The OTS was used to predict visual outcomes and the results were compared with outcomes gathered from statistical tests.

In the open-globe group six weeks postoperatively it was found that final corrected distance visual acuity (CDVA) was better than 20/200 in 181 eyes and 20/40 or better in 110 eyes. In the closed-globe group CDVA was better than 20/200 in 36 eyes and 20/40 or better in 15 eyes.

In total, 214 eyes presented with a final CDVA better than 20/200 and 123 eyes had a CDVA of 20/40 or better. This indicated that the OTS is a reliable predictor of the final visual outcome in paediatric patients with traumatic cataract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.